AbbVie To Buy Pharmacyclics For $21 Billion In A Mixed Cash And Stock Deal By: TalkMarkets March 05, 2015 at 12:57 PM EST With the high-priced acquisition scheduled to close mid-year, shares of PCYC are up 10% to above $254 per share. Read More >> Related Stocks: AbbVie Johnson & Johnson Novartis Ag ADR